Correction to: Targeted Oncology (2018) 13:269–285
Enhanced digital features were retrospectively added to this article.
To view enhanced digital features for this article go to https://doi.org/10.6084/m9.figshare.7094075.
Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
Author information
Authors and Affiliations
Corresponding author
Additional information
The online version of the original article can be found at https://doi.org/10.1007/s11523-018-0566-1
Rights and permissions
About this article
Cite this article
Hochmair, M. Correction to: Medical Treatment Options for Patients with Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer Suffering from Brain Metastases and/or Leptomeningeal Disease. Targ Oncol 13, 667 (2018). https://doi.org/10.1007/s11523-018-0598-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11523-018-0598-6